These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17600820)

  • 21. Benefits and menaces related to the use of statins in patients after renal transplantation.
    Chmielewski M; Zdrojewski Z; Rutkowski B
    Ann Transplant; 2002; 7(2):6-10. PubMed ID: 12416466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis.
    McAdams M; Staffa J; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):229-39. PubMed ID: 18175291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States.
    Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS
    Clin Ther; 2008 Jan; 30(1):195-205. PubMed ID: 18343257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin-associated exacerbation of myasthenia gravis.
    Cartwright MS; Jeffery DR; Nuss GR; Donofrio PD
    Neurology; 2004 Dec; 63(11):2188. PubMed ID: 15596782
    [No Abstract]   [Full Text] [Related]  

  • 25. SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia.
    Santos PC; Gagliardi AC; Miname MH; Chacra AP; Santos RD; Krieger JE; Pereira AC
    Eur J Clin Pharmacol; 2012 Mar; 68(3):273-9. PubMed ID: 21928084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients.
    Di Nisio M; Di Febbo C; Moretta V; Guglielmi MD; Stuppia L; Cuccurullo F; Porreca E
    Thromb Haemost; 2007 Sep; 98(3):642-6. PubMed ID: 17849054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The MEGA study.
    Moriguchi H; Uemura T; Sato C
    Lancet; 2006 Dec; 368(9552):2052; author reply 2052. PubMed ID: 17161725
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical and laboratory phenotype of patients experiencing statin intolerance attributable to myalgia.
    Harris LJ; Thapa R; Brown M; Pabbathi S; Childress RD; Heimberg M; Braden R; Elam MB
    J Clin Lipidol; 2011; 5(4):299-307. PubMed ID: 21784376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
    Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
    Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How common is rhabdomyolysis in patients receiving lipid-lowering therapy?
    Phillips PS
    Nat Clin Pract Cardiovasc Med; 2005 Mar; 2(3):130-1. PubMed ID: 16265453
    [No Abstract]   [Full Text] [Related]  

  • 31. Development of tachyphylaxis on statin treatment.
    Miserez AR; Keller U; Mirsaidi R
    Am J Cardiol; 2001 Oct; 88(8):936-7. PubMed ID: 11676971
    [No Abstract]   [Full Text] [Related]  

  • 32. Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials).
    Brilakis ES; de Lemos JA; Cannon CP; Wiviott SD; Murphy SA; Morrow DA; Sabatine MS; Banerjee S; Blazing MA; Califf RM; Braunwald E
    Am J Cardiol; 2008 Sep; 102(5):552-8. PubMed ID: 18721511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins.
    Santilli F; Bucciarelli L; Noto D; Cefalù AB; Davì V; Ferrante E; Pettinella C; Averna MR; Ciabattoni G; Davì G
    Free Radic Biol Med; 2007 Nov; 43(9):1255-62. PubMed ID: 17893038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probable statin-induced testicular pain.
    Linnebur SA; Hiatt WH
    Ann Pharmacother; 2007 Jan; 41(1):138-42. PubMed ID: 17200428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypothyroidism, pravastatin therapy and myopathy].
    Porela P; Kantola I
    Duodecim; 2002; 118(7):689-90. PubMed ID: 12238178
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of genetic variants associated with response to statin therapy.
    Mega JL; Morrow DA; Brown A; Cannon CP; Sabatine MS
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1310-5. PubMed ID: 19667110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gitelman's syndrome presenting as intolerance to statin therapy.
    Freedman DB; Housley D
    Ann Clin Biochem; 2005 May; 42(Pt 3):232-3. PubMed ID: 15949161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Class effects of statins in elderly patients with congestive heart failure: a population-based analysis.
    Rinfret S; Behlouli H; Eisenberg MJ; Humphries K; Tu JV; Pilote L
    Am Heart J; 2008 Feb; 155(2):316-23. PubMed ID: 18215603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.
    Patti G; Nusca A; Chello M; Pasceri V; D'Ambrosio A; Vetrovec GW; Di Sciascio G
    Am J Cardiol; 2008 Feb; 101(3):279-85. PubMed ID: 18237585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ranolazine-induced myopathy in a patient on chronic statin therapy.
    Correa D; Landau M
    J Clin Neuromuscul Dis; 2013 Mar; 14(3):114-6. PubMed ID: 23492463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.